'Mad Money' host Jim Cramer weighs in on stock including: Navitas, Regeneron and Landbridge. Crowds celebrate as South Korean ...

Mad Money” host Jim Cramer rings the lightning round bell, which means he’s giving his answers to callers’ stock questions at ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Shares of Eli Lilly & Co. LLY advanced 1.69% to $813.33 Tuesday, on what proved to be an all-around mixed trading session for ...

Adam Coons, chief investment officer at Winthrop Capital Management, says Eli Lilly's weight loss drug is positioning the company for continued growth, as the need "to mitigate obesity" is not going ...

Eli Lilly has removed the commonly used clinical measure of body mass index from the FDA label for its weight loss drug ...

In response to lawmakers' concerns, Pfizer and Eli Lilly said last week that they do not influence telehealth partners and ...

And this was met by an arm we call modified titration. It met that primary objective and that ARIA-E frequency was 14% for the modified titration versus 24% for the standard dosing. And so this ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 505.84% and ...

Artificial intelligence (AI) is changing the way companies do business -- helping programmers write code and fielding ...

Pharma vs pushes back as Senators look into telehealth moves, startups using AI for small molecule drugs, and more.

Brand companies who own GLP-1 products have been pushing the Food and Drug Administration (FDA) to limit their compounding. On August 28, 2024, ...